title: Why We Have to Use Cardiac Resynchronization Therapy-Pacemaker More.
abstract: Both cardiac resynchronization therapy with a pacemaker (CRT-P) and with a biventricular implantable cardioverter-defibrillator (CRT-D) are electrical treatment modalities validated for the management of chronic heart failure. There is no strong scientific evidence that a CRT-D must be offered to all candidates. Common sense should limit the prescription of these costly and complicated devices. The choice of CRT-P is currently acceptable. A direction to explore could be to downgrade from CRT-D to CRT-P at the time of battery depletion in patients with large reverse remodeling and no ventricular tachycardia and ventricular fibrillation detected.
authors.affiliation: University of Rennes, Rennes 35000, France. Electronic address: jcdaubert@orange.fr.
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Daubert
authors.affiliation: University of Rennes, Rennes 35000, France.
authors.forename: Raphaël
authors.initials: R
authors.lastname: Martins
authors.affiliation: University of Rennes, Rennes 35000, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Leclercq
mesh_terms: D058406:Cardiac Resynchronization Therapy / Q000401:mortality / Q000706:statistics & numerical data*; D003131:Combined Modality Therapy / Q000401:mortality / Q000706:statistics & numerical data; D016757:Death, Sudden, Cardiac / Q000453:epidemiology* / Q000517:prevention & control*; D017147:Defibrillators, Implantable / Q000706:statistics & numerical data*; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000401:mortality* / Q000517:prevention & control*; D006801:Humans; D018579:Patient Selection; D015995:Prevalence; D011379:Prognosis; D018570:Risk Assessment; D015996:Survival Rate
keywords: Cardiac resynchronization therapy; Chronic heart failure; Pacemaker